Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Global Utilization and Registry Database for Improved Preservation of Donor Lungs

NCT04930289 is registered in ClinicalTrials.gov with Paragonix Technologies as lead sponsor.

NCT NCT04930289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04930289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Global Utilization and Registry Database for Improved Preservation of Donor Lungs
Lead sponsor
Paragonix Technologies
Phase
Observational
Overall status
Enrolling by invitation
Start date
October 15, 2021
Completion date
December 30, 2029
Enrollment
3,500 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

copd, cystic fibrosis, emphysema, interstitial lung disease, pulmonary arterial hypertension, pulmonary fibrosis